Correlation of caspase-3 activation with cytochrome c release in different clinical response groups
Group . | Cytochrome c release, total . | Cytochrome c release, caspase dependent . | Cytochrome c release, caspase independent . |
|---|---|---|---|
| Total | |||
| rs | -0.290* | 0.361* | -0.019 |
| P | .010 | .001 | .870 |
| Day 8, prednisone response | |||
| Good | |||
| rs | 0.295* | 0.428* | 0.009 |
| P | .016 | <.001 | .942 |
| Poor | |||
| rs | 0.308 | -0.065 | 0.258 |
| P | .330 | .840 | .418 |
| Day 15, blast cell persistence | |||
| Less than 5% | |||
| rs | -0.441* | 0.502* | -0.050 |
| P | .007 | .002 | .772 |
| More than 5% | |||
| rs | -0.256 | -0.020 | -0.288 |
| P | .198 | .922 | .146 |
| Day 33, remission | |||
| Yes | |||
| rs | -0.274* | 0.375* | -0.012 |
| P | .018 | .001 | .921 |
| No | |||
| rs | -0.400 | -0.200 | -0.800 |
| P | .600 | .800 | .200 |
| Relapse | |||
| No | |||
| rs | -0.307* | 0.375* | -0.022 |
| P | .016 | .003 | .866 |
| Yes | |||
| rs | -0.275 | 0.379 | -0.177 |
| P | .286 | .133 | .497 |
Group . | Cytochrome c release, total . | Cytochrome c release, caspase dependent . | Cytochrome c release, caspase independent . |
|---|---|---|---|
| Total | |||
| rs | -0.290* | 0.361* | -0.019 |
| P | .010 | .001 | .870 |
| Day 8, prednisone response | |||
| Good | |||
| rs | 0.295* | 0.428* | 0.009 |
| P | .016 | <.001 | .942 |
| Poor | |||
| rs | 0.308 | -0.065 | 0.258 |
| P | .330 | .840 | .418 |
| Day 15, blast cell persistence | |||
| Less than 5% | |||
| rs | -0.441* | 0.502* | -0.050 |
| P | .007 | .002 | .772 |
| More than 5% | |||
| rs | -0.256 | -0.020 | -0.288 |
| P | .198 | .922 | .146 |
| Day 33, remission | |||
| Yes | |||
| rs | -0.274* | 0.375* | -0.012 |
| P | .018 | .001 | .921 |
| No | |||
| rs | -0.400 | -0.200 | -0.800 |
| P | .600 | .800 | .200 |
| Relapse | |||
| No | |||
| rs | -0.307* | 0.375* | -0.022 |
| P | .016 | .003 | .866 |
| Yes | |||
| rs | -0.275 | 0.379 | -0.177 |
| P | .286 | .133 | .497 |
Total n = 78. On day 8, for patients with good prednisone response, n = 66; with poor response, n = 12. On day 15, for patients with less than 5% blast cell persistence, n = 36; for more than 5% persistence, n = 27. On day 33, for patients in remission, n = 74; for patients not in remission, n = 4. For patients not experiencing relapse, n = 61; for those with relapse, n = 17.
rs indicates correlation coefficient; P, significance.
Correlation is significant (2-tailed).